Ignite Creation Date:
2025-12-24 @ 2:53 PM
Ignite Modification Date:
2026-02-21 @ 11:36 PM
Study NCT ID:
NCT01691859
Status:
COMPLETED
Last Update Posted:
2023-06-28
First Post:
2012-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-31
Completion Date Type:
ACTUAL
First Submit Date:
2012-09-13
First Submit QC Date:
None
Study First Post Date:
2012-09-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-04-19
Results First Submit QC Date:
None
Results First Post Date:
2018-05-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-09
Last Update Post Date:
2023-06-28
Last Update Post Date Type:
ACTUAL